Is the matched extreme case–control design more powerful than the nested case–control design?

2018 ◽  
Vol 28 (6) ◽  
pp. 1911-1923 ◽  
Author(s):  
NC Støer ◽  
A Salim ◽  
K Bokenberger ◽  
I Karlsson ◽  
M Reilly

For time-to-event data, the study sample is commonly selected using the nested case–control design in which controls are selected at the event time of each case. An alternative sampling strategy is to sample all controls at the same (pre-specified) time, which can either be at the last event time or further out in time. Such controls are the long-term survivors and may therefore constitute a more ‘extreme’ comparison group and be more informative than controls from the nested case–control design. We investigate this potential information gain by comparing the power of various ‘extreme’ case–control designs with that of the nested case–control design using simulation studies. We derive an expression for the theoretical average information in a nested and extreme case–control pair for the situation of a single binary exposure. Comparisons reveal that the efficiency of the extreme case–control design increases when the controls are sampled further out in time. In an application to a study of dementia, we identified Apolipoprotein E as a risk factor using a 1:1 extreme case–control design, which provided a hazard ratio estimate with a smaller standard error than that of a 2:1 nested case–control design.

2019 ◽  
Vol 15 ◽  
pp. 117693431983882
Author(s):  
Young Min Kim ◽  
Jongho Im

Nested case-control sampling design is a popular method in a cohort study whose events are often rare. The controls are randomly selected with or without the matching variable fully observed across all cohort samples to control confounding factors. In this article, we propose a new nested case-control sampling design incorporating both extreme case-control design and a resampling technique. This new algorithm has two main advantages with respect to the conventional nested case-control design. First, it inherits the strength of extreme case-control design such that it does not require the risk sets in each event time to be specified. Second, the target number of controls can only be determined by the budget and time constraints and the resampling method allows an under sampling design, which means that the total number of sampled controls can be smaller than the number of cases. A simulation study demonstrated that the proposed algorithm performs well even when we have a smaller number of controls compared with the number of cases. The proposed sampling algorithm is applied to a public data collected for “Thorotrast Study.”


2020 ◽  
Author(s):  
Christopher Partlett ◽  
Nigel J Hall ◽  
Alison Leaf ◽  
Edmund Juszczak ◽  
Louise Linsell

Abstract Background A nested case-control study is an efficient design that can be embedded within an existing cohort study or randomised trial. It has a number of advantages compared to the conventional case-control design, and has the potential to answer important research questions using untapped prospectively collected data. Methods We demonstrate the utility of the matched nested case-control design by applying it to a secondary analysis of the Abnormal Doppler Enteral Prescription Trial. We investigated the role of milk feed type and changes in milk feed type in the development of necrotising enterocolitis in a group of 398 high risk growth-restricted preterm infants. Results Using matching, we were able to generate a comparable sample of controls selected from the same population as the cases. In contrast to the standard case-control design, exposure status was ascertained prior to the outcome event occurring and the comparison between the cases and matched controls could be made at the point at which the event occurred. This enabled us to reliably investigate the temporal relationship between feed type and necrotising enterocolitis. Conclusions A matched nested case-control study can be used to identify credible associations in a secondary analysis of clinical trial data where the exposure of interest was not randomised, and has several advantages over a standard case-control design. This method offers the potential to make reliable inferences in scenarios where it would be unethical or impractical to perform a randomised clinical trial.


2012 ◽  
Vol 95 (2) ◽  
pp. 471-478 ◽  
Author(s):  
Suvi M Virtanen ◽  
Jaakko Nevalainen ◽  
Carina Kronberg-Kippilä ◽  
Suvi Ahonen ◽  
Heli Tapanainen ◽  
...  

2019 ◽  
Author(s):  
Christopher Partlett ◽  
Nigel J Hall ◽  
Alison Leaf ◽  
Edmund Juszczak ◽  
Louise Linsell

Abstract Background: A nested case-control study is an efficient design that can be embedded within an existing cohort study or randomised trial. It has a number of advantages compared to the conventional case-control design, and has the potential to answer important research questions using untapped prospectively collected data.Methods: We demonstrate the utility of the matched nested case-control design by applying it to a secondary analysis of the Abnormal Doppler Enteral Prescription Trial. We investigated the role of milk feed type and changes in milk feed type in the development of necrotising enterocolitis in a group of 398 high risk growth-restricted preterm infants. Results: Using matching, we were able to generate a comparable sample of controls selected from the same population as the cases. In contrast to the standard case-control design, exposure status was ascertained prior to the outcome event occurring and the comparison between the cases and matched controls could be made at the point at which the event occurred. This enabled us to reliably investigate the temporal relationship between feed type and NEC. Conclusions: A matched nested case-control study can be used to identify credible associations in a secondary analysis of clinical trial data where the exposure of interest was not randomised, and has several advantages over a standard case-control design. This method offers the potential to make reliable inferences in scenarios where it would be unethical or impractical to perform a randomised clinical trial.


2010 ◽  
Vol 46 (4) ◽  
pp. 782-790 ◽  
Author(s):  
M.C. Cardous-Ubbink ◽  
M.M. Geenen ◽  
K.J. Schade ◽  
R.C. Heinen ◽  
H.N. Caron ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document